SEC-sourced researchBeta
BGM
BGM Group Ltd.
Company comparison ↗
Data passport
- CIK
- 0001779578
- Exchange
- Nasdaq
- Business activity
- Pharmaceutical Preparations · SIC 2834
- Financial inputs
- 6/6
- Filing date
- Sep 24, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| September 2023 | 46,471,478.0000 | Jul 21, 2026 |
| September 2024 | 25,097,951.0000 | Jul 21, 2026 |
| September 2025 | 37,919,425.0000 | Jul 21, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| September 2025 | 37,919,425.0000 | -19,941,242.0000 | -2,372,437.0000 | 433,814,485.0000 | 41,916,992.0000 | Jul 21, 2026 |
| September 2024 | 25,097,951.0000 | -1,442,830.0000 | 544,238.0000 | 53,003,728.0000 | 8,910,379.0000 | Jul 21, 2026 |
| September 2023 | 46,471,478.0000 | -7,780,620.0000 | 312,209.0000 | — | — | Jul 21, 2026 |
Explainable fundamental score
Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.
65/100
Profitability0
Growth100
Balance sheet90
Cash generation37
Data coverage100
Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $37.92M | Oct 1, 2024 – Sep 30, 2025 | Jul 21, 2026 | 20-F |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $25.1M | Oct 1, 2023 – Sep 30, 2024 | Jul 21, 2026 | 20-F |
| Net incomeNetIncomeLoss | -$19.94M | Oct 1, 2024 – Sep 30, 2025 | Jul 21, 2026 | 20-F |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$2.37M | Oct 1, 2024 – Sep 30, 2025 | Jul 21, 2026 | 20-F |
| Total assetsAssets | $433.81M | Sep 30, 2025 | Jul 21, 2026 | 20-F |
| Total liabilitiesLiabilities | $41.92M | Sep 30, 2025 | Jul 21, 2026 | 20-F |